HRP Avidin

Pricing & Availability
Regulatory Status
RUO
Other Names
Avidin-Peroxidase, Avidin-Horseradish Peroxidase, Av-HRP
Cat # Size Price Quantity Check Availability
405103 1 mL $129.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Avidin binds to biotin with high affinity. Avidin-HRP is useful for detecting biotinylated antibodies, e.g., in ELISA or Western blotting. For ELISA applications, HRP will act on soluble substrates, such as ABTS or TMB, to yield a colorimetric reaction. For Western blotting or ELISPOT applications, HRP will act on precipitating substrates, such as 4CN, to yield a colorimetric reaction.

Technical data sheet

Product Details

Formulation
Buffered solution containing bovine protein and preservatives (methylisothiazolone, bromonitrodioxane, and other active isothiazolones).
Preparation
Avidin is conjugated with horseradish peroxidase under optimal conditions.
Storage & Handling
Upon receipt, the antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Avoid exposure to sodium azide.
Application

ELISA - Quality tested
ELISPOT, IHC, WB - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by ELISA assay. For ELISA or Western blot analysis, the reagent should be titrated between 1:1000 - 1:5000 to determine optimal conditions. For ELISPOT, dilute at 1:500 - 1:2500 to determine optimal conditions. Avoid using biotin-containing solutions as diluents and solutions containing sodium azide. Sodium azide is an inhibitor of horseradish peroxidase. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Avidin-HRP is useful as a second step reagent for indirect enzymatic labelling, in conjunction with biotinylated primary antibodies. Av-HRP is recommended for ELISA, ELISPOT and Western blotting, when used with the relevant substrate system.

Application References

(PubMed link indicates BioLegend citation)
  1. Qiu LQ, et al. 2012. J Immunol. 188:5150. PubMed
  2. McLaughlin HP, et al. 2013. J Med Microbiol. 62:185. PubMed
  3. Chan WL, et al. 2013. Nucleic Acids Res. 41:3734. PubMed
  4. Macauley MS, et al. 2014. J Biol Chem. 289:351489. PubMed
  5. Roncolato EC, et al. 2015. Infect Immun. 83:713. PubMed
Product Citations
  1. Altemus J, et al. 2022. J Cell Physiol. 237:3001. PubMed
  2. Vazquez-Lombardi R, et al. 2022. Immunity. 55:1953. PubMed
  3. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  4. Bracho-Sanchez E, et al. 2023. Nat Biomed Eng. . PubMed
  5. Soe PP, et al. 2023. Int J Mol Sci. 24:. PubMed
  6. Clausen TM, et al. 2020. Cell. 183:1043. PubMed
  7. Montégut L, et al. 2022. STAR Protoc. 3:101095. PubMed
  8. Yuan S, et al. 2021. Nature. 593:418. PubMed
  9. Clausen TM, et al. 2020. bioRxiv. . PubMed
  10. Roncolato E, et al. 2015. Infect Immun . 83:713. PubMed
  11. Qiu L, et al. 2012. J Immunol. 188:5150. PubMed
  12. Wu J, et al. 2020. Immunity. 53:115. PubMed
  13. McLaughlin H, et al. 2013. J Med Microbiol. 62:185. PubMed
  14. Chan W, et al. 2013. Nucleic Acids Res. 41:3734. PubMed
  15. Tada R, et al. 2015. PLoS One. 10: e0139785. PubMed
  16. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  17. Macauley M, et al. 2014. J Biol Chem. 289:35149. PubMed
  18. Kojima H, et al. 2021. Scand J Immunol. 93:e13020. PubMed
  19. Narayanasamy A, et al. 2011. J Proteomics. 74:2948. PubMed
  20. Heinzel C, et al. 2021. Front Immunol. 12:753435. PubMed
  21. Salehi S, et al. 2017. PLoS One. 10.1371/journal.pone.0163614. PubMed
  22. Yabe R, et al. 2021. Nat Commun. 0.565277778. PubMed
  23. Tan EE, et al. 2020. J Clin Invest. 130:5817. PubMed
Go To Top Version: 3    Revision Date: 01/31/2020

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Login/Register
Forgot your password? Reset Password
Request an Account